miR-490-3p could play vital roles in multiple cancers. However, the role of miR-490-3p in hepatocellular carcinoma (HCC) remains uncertain. In this study, we sought to explore the underlying role of miR-490-3p in HCC.
Investigation of miR-490-3p Expression in

Background
Hepatocellular carcinoma (HCC) is a primary liver neoplasm. Although some risk factors (e.g., hepatitis B virus infection and overconsumption of alcohol) for HCC have been recognized, the exact molecular mechanism of HCC development remain unclear [1, 2] . Elucidation of the molecular pathways related to HCC will help to develop new therapeutic targets [3, 4] . miRNAs are a class of short, endogenous, evolutionarily conserved, and single-stranded non-coding RNA molecules that can regulate gene expression through the inhibition of translation and the degradation of mRNA (5) (6) (7) (8) . MiRNAs have been reported to play vital roles in various significant biological processes, including proliferation, the cell cycle, migration, and differentiation [9] [10] [11] . Additionally, miRNAs can act as tumor suppressors or oncogenes [12] [13] [14] . Emerging evidence demonstrates that many tumor-specific miRNAs are widely downregulated or up-regulated in HCC and are closely related to the tumorigenesis and development of HCC [15] [16] [17] .
miR-490-3p has been demonstrated to be associated with the metastasis, proliferation, and apoptosis of different cancers [18, 19] . For example, miR-490-3p can inhibit the metastasis of colorectal cancer via targeting TGFbR1 [18] . In osteosarcoma, miR-490-3p can affect cell proliferation and apoptosis by targeting HMGA2 [19] . To date, the expression and role of miR-490-3p has rarely been investigated in HCC. Wojcicka et al. [20] reported a down-regulated expression of miR-490-3p, whereas an up-regulated expression of miR-490-3p in HCC tissues was found by Zhang et al. [21] . These published studies show that the miR-490-3p expression level is controversial in HCC.
In the present study, we sought to assess the miR-490-3p expression in HCC and normal liver tissue. Furthermore, we combined quantitative reverse transcription-polymerase chain reactions (RT-qPCR), The Cancer Genome Atlas (TCGA), and a meta-analysis to evaluate the clinical role and the underlying molecular mechanism of miR-490-3p in HCC. Additionally, bioinformatics analyses were applied to explore the possible functions, pathways, and networks of the potential genes [22] .
Material and Methods
Quantitative real-time PCR
A total of 82 samples (41 HCC and 41 normal liver) were collected from the Department of Pathology, First Affiliated Hospital of Guangxi Medical University (Nanning, Guangxi, China). All experimental procedures were approved by the Ethics Committee of the First Affiliated Hospital of Guangxi Medical University, and both the clinicians and patients signed the consent forms for the use of tissues in the study. Additionally, all the experimental methods were performed according to the manufacturer's instructions. In this study, TRIzol reagent (Takara, Nanning, China) was used to extract the total RNA, and then the extracted RNA was reverse-transcribed to cDNA using the Takara PrimeScript RT Reagent Kit (Takara, Nanning, China). Then, RT-qPCR was performed with the LightCycler 480 Realtime PCR System (Roche, Shanghai, China). The specific primers were as follows: miR-490-3p: CAACCUGGAGGACUCCAUGCUG; miR-191: CAACGGAAUCCCAAAAGCAGCU; miR-103: AGCAGCA UUGUACAGGGCUAUGA. The data were normalized to miR-191 and miR-103 expression levels and calculated using the 2 -DDCT method [23, 24] .
MiR-490-3p and HCC: A meta-analysis
The HCC-related miR-490-3p RNA-seq and microarray datasets were downloaded from TCGA 
Validation the miR-490-3p expression in HCC
TCGA is a collection of data, including miRNA-seq, RNA-seq, exome-seq, SNP array, and DNA methylation [25, 26] . In this study, the HCC RNA-seq (level 3, normalized read counts) of tumors and normal tissues was downloaded from TCGA [27] . The expression data of miR-490-3p were exhibited as reads per million (RPM), and the expression level of miR-490-3p was normalized by the Deseq package of R language. We used the t test (SPSS Inc., Chicago, IL, USA) for the statistical analysis of the differential expression of miR-490-3p between HCC and normal liver tissues. Additionally, the relationship between miR-490-3p and the clinicopathological parameters in HCC was surveyed according to the original data in the TCGA database. Then, a receiver operating characteristic (ROC) curve was generated to analyze the clinical diagnostic value of miR-490-3p in HCC. Furthermore, Kaplan-Meier method was used to assess the relationship between miR-490-3p expression and overall survival.
The potential functions and pathways associated with miR-490-3p
To further investigate the target genes of miR-490-3p, 12 online target prediction algorithms were applied to predict the underlying target genes of miR-490-3p. Genes predicted by more than 5 target prediction algorithms were chosen for further analysis.
The differentially expressed genes of HCC in the Gene Expression Profiling Interactive Analysis (GEPIA) database were selected. Venn diagrams were created to identify the overlapping target genes from the prediction algorithms and the GEPIA database.
In addition, bioinformatics analyses (Gene Ontology (GO), Kyoto Encyclopedia of Genes and Genomes (KEGG) and network analysis) were utilized to investigate the possible functions, pathways, and networks of the potential genes as described [28, 29] . In this process, the Database for Annotation, Visualization, and Integrated Discovery (DAVID: available online: http://david.abcc.ncifcrf.gov/) was applied, and a functional network was established via Cytoscape (version 3.0, http:// cytoscape.org) [30] .
Statistical analysis
All the expression data in TCGA were log2-transformed. The differences in miR-490-3p expression between HCC and noncancerous liver were estimated by use of the t test, which was In the meta-analysis, all statistical analyses were performed in STATA 14.0 (STATA Corp., College Station, Texas). The heterogeneity of the included studies was measured by Cochrane's Q test and the I 2 statistic, and I 2 >50% represented obvious heterogeneity. Publication bias was assessed via Deek's funnel plot asymmetry test; a P-value<0.05 indicated significant publication bias. To determine the diagnostic value of miR-490-3p in HCC, we applied summary receiver operating characteristic (SROC) curves to calculate the area under the curve (AUC) with 95% CIs, and the corresponding sensitivity and specificity were also identified using Meta-DiSc software [31] . We also used STATA 14.0 to conduct a continuous variable meta-analysis.
Results
The clinical value of miR-490-3p expression in HCC We found that miR-490-3p was clearly down-regulated in HCC, based on RT-qPCR (P=0.002, Figure 1A) . Additionally, the area under the curve (AUC) of miR-490-3p was 0.695 (95% CI: 0.581-0.808, P=0.002, Figure 1B) , indicating a moderate diagnostic value of the miR-490-3p level in HCC. Consistent with the results of RT-qPCR, miR-490 was more highly expressed in normal liver tissue than in HCC tissue (P<0.001, Figure 1C) , and the AUC of miR-490-3p was 0.891 (95% CI: 0.844-0.938, P<0.001, Figure 1D ) based on TCGA. Additionally, we observed that high miR-490 expression was correlated with better survival compared to the survival of the low miR-490 expression group (P=0.006, Figure 1E ) for patients with HCC. We also explored the relationship between different levels of miR-490-3p expression and clinicopathological parameters, but no statistical significance was found, partly because of the small sample size (Tables 1, 2 
MiR-490-3p and HCC: A meta-analysis
The meta-analysis included 749 cases from 3 sources: 8 datasets in GEO (GSE98269, GSE74618, GSE57555, GSE41874, GSE40744, GSE31383, GSE21362 and GSE12717); the original data in TCGA; and the expression data from the RT-qPCR. For the miR-490-3p expression in HCC compared to the normal group, a fixed-effects model was used to calculate the standard mean deviation (SMD) and 95% CI. The combined SMD reached -0.52 (-0.71, -0.34), indicating that miR-490-3p expression was down-regulated in HCC (P<0.001, Figure 2A ). Considering the high heterogeneity (I 2 =86.7%, P<0.05) of SMD, a random-effects model was then applied, and the combined SMD reached -0.20 (-0.78, 0.37) with heterogeneity over 50% ( Figure 2B ). Then, we performed sensitivity analysis to clarify whether the high heterogeneity was from one particular study, and the results showed the pooled SMD was stable ( Figure 2C ). Furthermore, no significant publication bias could be found (P>0.05, Figure 2D ).
In diagnostic meta-analysis, The DLR-negative was 0.38 (0.09-1.59), and the DLR-positive was 1.98 (1.11-3.56, Figure 3A) . A PLR value of 1.98 suggested that patients with HCC had an approximately 1.98-fold higher chance of being miR-490-3p assay-positive. The diagnostic score was 1.65 (0.07-3.23) and the odds ratio was 5.21 (1.07-25.39, Figure 3B ). Moreover, we also investigated the diagnostic value of miR-490-3p in HCC via the diagnostic meta-analysis. The sensitivity and specificity were 0.77 (95% CI: 0.24-0.97) and 0.61 (95% CI: 0.28-0.87), respectively ( Figure 3C ). The AUC of SROC Figure 3D ), which shows the accuracy of miR-490-3p for the detection of HCC. Additionally, our results confirmed the moderate diagnostic accuracy of miR-490-3p, as already shown by TCGA and RT-qPCR. No obvious publication bias was found (P>0.05, Figure 3E ).
The potential pathways associated with miR-490-3p
Based on the target prediction algorithms and the GEPIA database, 113 overlapping genes were selected (Figure 4) . Bioinformatics analyses were performed on these 113 genes. According to GO and KEGG analyses, we found that the most remarkably enriched functional terms were protein transport, poly(A) RNA binding, and intracellular organelle part (Table 3) . Additionally, the miR-490-3p target genes were significantly related to pathways in cancer (Table 4) . Finally, a gene network of the overlapped genes was constructed ( Figure 5 ), and the relationships between miR-490-3p and the target genes could be easily observed from the network.
Discussion
Many studies have demonstrated that miRNAs are involved in various biological processes of HCC, such as cell proliferation, invasion, migration, and the cell cycle [9, 32, 33] . Additionally, miRNAs can act as diagnostic and prognostic biomarkers in The si erentially expressed genes of HCC A total of 113 genes were selected based on the target prediction aldoritms and GEPIA database HCC [34, 35] . In the present study, we explored the underlying role of miR-490-3p in HCC. Few previous studies have focused on the detailed role of miR-490-3p in HCC. Wojcicka et al. [20] explored the deregulated miRNAs in liver cirrhosis and HCC via next-generation sequencing, and confirmed the down-regulation of miR-490-3p (T/N=0.13) in HCC. However, Zhang et al. [21] found that miR-490-3p was highly expressed in HCC cells via RT-qPCR and that miR-490-3p functions as an oncogenic miRNA in HCC cells, which is inconsistent with our RT-qPCR and TCGA results. In the present study, miR-490-3p was clearly down-regulated in HCC, as shown by RT-qPCR and TCGA. Additionally, the combined SMD of the expression meta-analysis reached -0.52 (-0.70, -0.33), indicating down-regulated expression of miR-490-3p in HCC. Moreover, the present study, which included 749 cases from 3 sources (GEO, TCGA and RT-qPCR), is the first meta-analysis to survey the expression and diagnostic value of miR-490-3p in HCC. We used diagnostic meta-analysis to assess the validity of using miR-490-3p to detect HCC. The results of SROC showed the moderate diagnostic value of miR-490-3p for the detection of HCC. Additionally, the results of our meta-analysis confirmed the diagnostic accuracy of miR-490-3p, based on TCGA and RTqPCR. However, high heterogeneity (high I2 values) was unavoidable in this meta-analysis, partly because of the opposite results in the study by Zhang et al. Furthermore, blinding in the 3 different sources was not certain, which also contributed to the high heterogeneity, and no individual publications could be included in this meta-analysis.
According to GO and KEGG analyses, we found the enriched functional terms were protein transport, poly(A) RNA binding, and intracellular organelle part. Additionally, the miR-490-3p target genes were significantly related to the pathways in cancer. As reported, miR-490-3p is involved in the tumorigenesis and development of various cancers, such as ovarian carcinoma and breast cancer, via interacting with mRNA [36, 37] .
Conclusions
We hypothesized that miR-490-3p plays a significant role in HCC via regulating various pathways, especially pathways in cancer. However, the suspected mechanism should be confirmed by functional experiments, such as proliferation, invasion, metastasis, cell cycle, and apoptosis assays, and in animal models. The molecular mechanism by which miR-490-3p affects the biological function of HCC needs to be assessed from the cell, tissue, and animal levels. Focusing on new insights into miR-490-3p, our study provides a new perspective on HCC.
